Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Best Defense Is Good Offense: PhRMA Wants PBMs To 'Share The Savings'

Executive Summary

PhRMA ad campaign targets US payer practice of using drug rebate dollars for general premium and cost sharing reductions and not to lower the cost of specific prescription fills.

You may also be interested in...



Rebate Reform: West Virginia Law Requires PBMs To Share The Savings

First-of-its-kind state law requires 100% of rebates be redirected to offset patient cost sharing at the point of sale in commercial insurance plans.

UnitedHealthcare Will Share The Savings: Point-Of-Sale Rebates Coming In 2019

Biggest benefit to manufacturers from the insurer's upcoming program may be relieving public pressure on list prices.

The Rebate Debate: Forbes Panelists On How Rebates Trickle Down To Patients

Express Scripts CEO Timothy Wentworth and PhRMA President Steven Ubl discussed some of the issues around drug rebating practices at the Forbes Healthcare Summit, including point-of-sale rebates.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS120389

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel